Comparison of the In Vivo Pharmacokinetics and In Vitro Dissolution of Branded Versus Generic Efavirenz Formulation in HIV-Infected Patients-Reference-Cited by-同舟云学术

Comparison of the In Vivo Pharmacokinetics and In Vitro Dissolution of Branded Versus Generic Efavirenz Formulation in HIV-Infected Patients

Published:2016-06 Issue:3 Volume:38 Page:420-422
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Gervasoni Cristina,Baldelli Sara,Cerea Matteo,Cenderello Giovanni,Bini Teresa,Vimercati Stefania,Iardino Rosaria,Gazzaniga Andrea,D'Arminio Monforte Antonella,Clementi Emilio,Cattaneo Dario

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference11 articles.

1. Projected lifetime healthcare costs associated with HIV infection;Nakagawa;PLoS One,2015

2. Predicted savings to the UK National health Service from switching to generic antiretrovirals, 2014-2018;Hill;J Int AIDS Soc,2014

3. Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States;Walensky;Ann Intern Med,2013

4. Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs;Homar;Health Econ Rev,2012

5. Quality of antiretroviral and opportunistic infection medications dispensed from developing countries and internet pharmacies;Wang;J Clin Pharm Ther,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Case of Dolutegravir Plus Darunavir Antiretroviral Regimens: Is It Always Useful to Double the Drug Doses? A Short Communication;Therapeutic Drug Monitoring;2024-09-05

2. Untimed Efavirenz Drug Levels After Switching From Brand to Generic Formulations: A Short Communication;Therapeutic Drug Monitoring;2021-10

3. A Comparison of Tenofovir Predose Concentrations in Generic Pre-exposure Prophylaxis Formulations: A Short Communication;Therapeutic Drug Monitoring;2020-08

4. Generic antiretrovirals for the treatment of HIV: a novel challenge for Western countries?;Int. Journal of Clinical Pharmacology and Therapeutics;2017-05-01